The Addition of CD20 Monoclonal Antibodies to Lenalidomide Improves Response Rates and Survival in Relapsed/refractory patients with CLL Relative to Lenalidomide Monotherapy – The MD Anderson Cancer Center Experience

Saved in:

Bibliographic Details
Published in:	Br J Haematol
Main Authors:	Thompson, Philip A., Rosovski, Uri, Keating, Michael J., Stingo, Francesco, Smith, Susan C., Wierda, William G., Falchi, Lorenzo, O'Brien, Susan M., Estrov, Zeev, Burger, Jan A., Ferrajoli, Alessandra
Format:	Artigo
Language:	Inglês
Published:	2015
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4589497/ https://ncbi.nlm.nih.gov/pubmed/25824652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13377
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items